Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment

Journal of Infectious Diseases

Volumn 193, Issue 7, 2006, Pages 971-977

  Donati, Daria ^a   Espmark, Eva ^b   Kironde, Fred ^d   Mbidde, Edward Katongole ^e   Kamya, Moses ^d   Lundkvist, Åke ^b,c   Wahlgren, Mats ^c   Bejarano, Maria Teresa ^a,c   Falk, Kerstin I ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d MAKERERE UNIVERSITY   (Uganda)

^e Ugandan Cancer Institute   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; FANSIDAR; VIRUS DNA;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BURKITT LYMPHOMA; CHILD; CLINICAL ARTICLE; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MALARIA; MALE; PERSISTENT VIRUS INFECTION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SAMPLING; UGANDA; VIRUS DETECTION; VIRUS LOAD; VIRUS REACTIVATION;

EID: 33645332610     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/500839     Document Type: Article

References (31)

1. Burkitt DP. The discovery of Burkitt's lymphoma. Cancer 1983;51: 1777-86.
2. Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 1978;22: 239-43.
3. Lam KM, Syed N, Whittle H, Crawford DH. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 1991;337:876-8.
4. Whittle HC, Brown J, Marsh K, et al. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 1984;312: 449-50.
5. Rasti N, Falk KI, Donati D, et al. Circulating Epstein-Barr virus in children living in malaria endemic areas. Scand J Immunology 2005; 61:461-5.
6. Moormann AM, Chelimo K, Sumba OP, et al. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 2005;191:1233-8.
7. Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience. Trop Med Int Health 2001;6: 891-8.
8. Staedke SG, Kamya MR, Dorsey G, et al. Amodiaquine, sulfadoxine/ pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 2001;358:368-74.
9. Enbom M, Strand A, Falk KI, Linde A. Detection of Epstein-Barr virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction. Sex Transm Dis 2001; 28:300-6.
10. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R, Vidaud M. Novel approach to quantitative polymerase chain reaction using realtime detection: application to the detection of gene amplification in breast cancer. Int J Cancer 1998;78:661-6.
11. Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol 2000;111: 239-46.
12. Stevens SJ, Pronk I, Middeldorp JM. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol 2001;39:1211-6.
13. Drouet E, Brousset P, Fares F, et al. High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease. J Med Virol 1999;57:383-9.
14. Snow RW, Nahlen B, Palmer A, Donnelly CA, Gupta S, Marsh K. Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. J Infect Dis 1998;177:819-22.
15. Whittle HC, Brown J, Marsh K, Blackman M, Jobe O, Shenton F. The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children. Clin Exp Immunol 1990;80:213-8.
16. Kimura H, Nishikawa K, Hoshino Y, Sofue A, Nishiyama Y, Morishima T. Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol (Berl) 2000;188:197-202.
17. Berger C, Day P, Meier G, Zingg W, Bossart W, Nadal D. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 2001;64:505-12.
18. Gan YJ, Sullivan JL, Sixbey JW. Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J Infect Dis 1994;170:436-9.
19. Donati D, Zhang LP, Chen Q, et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 2004;72: 5412-8.
20. Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005;79:1296-307.
21. Chen Q, Heddini A, Barragan A, Fernandez V, Pearce SF, Wahlgren M. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med 2000;192:1-10.
22. Takada K. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 1984;33:27-32.
23. Takeda T, Mizugaki Y, Matsubara L, Imai S, Koike T, Takada K. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1218-25.
24. Abou-Eisha A, Afifi M. Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes. Cell Biol Toxicol 2004;20: 303-11.
25. Sitki-Green DL, Edwards RH, Covington MM, Raab-Traub N. Biology of Epstein-Barr virus during infectious mononucleosis. J Infect Dis 2004;189:483-92.
26. Golden HD, Chang RS, Prescott W, Simpson E, Cooper TY. Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis 1973;127:471-3.
27. Hopwood PA, Brooks L, Parratt R, et al. Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients. Transplantation 2002;74: 194-202.
28. Baldanti F, Grossi P, Furione M, et al. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 2000;38:613-9.
29. Geser A, de The G, Lenoir G, Day NE, Williams EH. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer 1982;29:397-400.
30. Burkitt DP. Epidemiology of Burkitt's lymphoma. Proc R Soc Med 1971;64:909-10.
31. Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999;59:1188-91.